Increased vagal reflexes contribute to bronchoconstriction in asthma, Antig
en challenge of sensitized animals induces vagal hyperresponsiveness. This
review will discuss the evidence that eosinophils increase release of acety
lcholine from the parasympathetic nerves. After antigen challenge, eosinoph
ils are actively recruited to the airway nerves, possibly through expressio
n of chemotactic substances and adhesion molecules by the nerves. Tachykini
ns acting on neurokinin 1 receptors activate the eosinophils. Activated eos
inophils release eosinophil major basic protein (MBP), which is an endogeno
us antagonist for Mt muscarinic receptors. The M-2 muscarinic receptors on
the parasympathetic nerves in the lungs normally inhibit release of acetylc
holine. When Mt receptors are blocked by MBP, acetylcholine release is incr
eased, resulting in hyperresponsiveness. Neutralization of MBP with polyani
onic substances restores Mt receptor function and eliminates hyperresponsiv
eness. Antibodies to MBP prevent Mt receptor dysfunction and hyperresponsiv
eness, as do antibodies to the adhesion molecule very late antigen 4, which
prevent eosinophil migration. A low dose of dexamethasone, which does not
affect total eosinophil influx into the lungs and airways, prevents eosinop
hils from clustering around the nerves and prevents antigen-induced Mt dysf
unction and hyperresponsiveness. Furthermore, animal studies show that vira
l infections, which are important precipitants of asthma attacks, and expos
ure to air pollutants such as ozone can also activate airway eosinophils, l
eading to a chain of events similar to that seen after antigen challenge. F
inally, a similar clustering of eosinophils around airway nerves, as well a
s release of MBP onto the nerves, is seen in fatal asthma, suggesting that
similar mechanisms may be involved in human airway hyperresponsiveness.